Cullinan Oncology LLC (CGEM) — Cash Flow Quality Index
Cullinan Oncology LLC (CGEM) has a Cash Flow Quality Index of -0.15x as of June 2022. Operating cash flow of $-25.42 Million is below net income of $174.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CGEM strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cullinan Oncology LLC Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Cullinan Oncology LLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Cullinan Oncology LLC tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Cullinan Oncology LLC (2022–2022)
Year-by-year earnings quality comparison for Cullinan Oncology LLC. For live market cap and the full company financial profile, see Cullinan Oncology LLC market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.16x | $-126.66 Million | $109.19 Million | — |